These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2527896)

  • 1. Treatment of adolescents with major depression: implications of the DST and the melancholic clinical subtype.
    Robbins DR; Alessi NE; Colfer MV
    J Affect Disord; 1989; 17(2):99-104. PubMed ID: 2527896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroendocrine dysfunction and response to tricyclic antidepressants.
    Kirstein L
    J Clin Psychiatry; 1984 Sep; 45(9):385-6. PubMed ID: 6432772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dexamethasone suppression test (DST) in predicting response to desipramine and amitriptyline in depressed outpatients.
    Peselow ED; Goldring N; Stanley M; Barouche F; Fieve RR
    Int Clin Psychopharmacol; 1986 Jan; 1(1):17-23. PubMed ID: 3549869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexamethasone suppression test and selection of antidepressant medications.
    Greden JF; Kronfol Z; Gardner R; Feinberg M; Mukhopadhyay S; Albala AA; Carroll BJ
    J Affect Disord; 1981 Dec; 3(4):389-96. PubMed ID: 6459354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexamethasone suppression test status does not predict differential response to nortriptyline versus amitriptyline.
    Rush AJ; Weissenburger J; Vasavada N; Orsulak PJ; Fairchild CJ
    J Clin Psychopharmacol; 1988 Dec; 8(6):421-5. PubMed ID: 3069882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression.
    Sabelli HC; Fawcett J; Javaid JI; Bagri S
    Am J Psychiatry; 1983 Feb; 140(2):212-4. PubMed ID: 6849437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dexamethasone suppression test as a predictor of drug treatment response.
    Arató M; Rihmer Z; Szádóczky E; Grof P
    Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):649-52. PubMed ID: 6152343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pituitary-adrenal disinhibition in depression: marker of a subtype with characteristic clinical features and response to treatment?
    Brown WA; Qualls CB
    Psychiatry Res; 1981 Apr; 4(2):115-28. PubMed ID: 6939003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Psychotropic profile of essential antidepressants (amitriptyline, imipramine, desipramine, chlorimipramine): comparative study].
    Koszewska I; Beresewicz M; Puzyński S; Kalinowski A
    Psychiatr Pol; 1994; 28(1):27-38. PubMed ID: 8190817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum dexamethasone concentrations in endogenous depressives before, during, and after treatment: preliminary observations.
    Poland RE; Rubin RT; Lesser IM
    Biol Psychiatry; 1988 Apr; 23(7):705-10. PubMed ID: 3370267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tricyclic-resistant depression: treatment resistance or inadequate treatment?
    Lydiard RB
    J Clin Psychiatry; 1985 Oct; 46(10):412-7. PubMed ID: 3900051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The dexamethasone suppression test and treatment outcome in elderly depressed patients participating in a placebo-controlled multicenter trial involving moclobemide and nortriptyline.
    Kin NM; Nair NP; Amin M; Schwartz G; Ahmed SK; Holm P; Katona C; Kragh-Sorensen P; Klitgaard N; Song WY; West TE; Stage K
    Biol Psychiatry; 1997 Nov; 42(10):925-31. PubMed ID: 9359979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium carbonate addition in tricyclic antidepressant-resistant unipolar depression. Correlations with the neurobiologic actions of tricyclic antidepressant drugs and lithium ion on the serotonin system.
    de Montigny C; Cournoyer G; Morissette R; Langlois R; Caillé G
    Arch Gen Psychiatry; 1983 Dec; 40(12):1327-34. PubMed ID: 6418109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test in the identification subtypes of depression differentially responsive to antidepressants [proceedings].
    Brown WA; Haier RJ; Qualls CB
    Psychopharmacol Bull; 1981 Jan; 17(1):88-90. PubMed ID: 7232667
    [No Abstract]   [Full Text] [Related]  

  • 15. Dexamethasone suppression test and mood response to methylphenidate in primary depression.
    Brown P; Brawley P
    Am J Psychiatry; 1983 Aug; 140(8):990-3. PubMed ID: 6346911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The usefulness of DST in predicting response to antidepressants: a placebo-controlled study.
    Georgotas A; Stokes P; McCue RE; Dubow A; Welkowitz J; Friedman E; Fanelli C; Chang I; Cooper TB
    J Affect Disord; 1986; 11(1):21-8. PubMed ID: 2944924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive improvement associated with tricyclic antidepressant treatment of childhood major depressive illness.
    Staton RD; Wilson H; Brumback RA
    Percept Mot Skills; 1981 Aug; 53(1):219-34. PubMed ID: 7290870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dexamethasone suppression test in depressive illness: clinical correlates.
    Asnis GM; Halbreich U; Nathan RS; Ostrow L; Novacenko H; Endicott J; Sachar EJ
    Psychoneuroendocrinology; 1982; 7(4):295-301. PubMed ID: 6820157
    [No Abstract]   [Full Text] [Related]  

  • 19. Consistent reversal of abnormal DSTs after different antidepressant therapies in a patient with dementia.
    Wamboldt MZ; Kalin NH; Weiler SJ
    Am J Psychiatry; 1985 Jan; 142(1):100-3. PubMed ID: 3966566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depression: diagnosis and treatment with tricyclic antidepressants.
    Gold MS; Pottash AC
    Postgrad Med; 1981 Jun; 69(6):104-7, 110-7. PubMed ID: 6785731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.